Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere
  2. Departments and Schools
  3. Faculty Publications (via McMaster Experts)
Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/26538
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKavsak PA-
dc.contributor.authorHammarsten O-
dc.contributor.authorWorster A-
dc.contributor.authorSmith SW-
dc.contributor.authorApple FS-
dc.date.accessioned2021-06-08T17:57:27Z-
dc.date.issued2021-01-08-
dc.identifier.issn0009-9147-
dc.identifier.issn1530-8561-
dc.identifier.urihttp://hdl.handle.net/11375/26538-
dc.description.abstract<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged late in 2019 causing COVID-19 (coronavirus disease-2019) may adversely affect the cardiovascular system. Publications from Asia, Europe, and North America have identified cardiac troponin as an important prognostic indicator for patients hospitalized with COVID-19. We recognized from publications within the first 6 months of the pandemic that there has been much uncertainty on the reporting, interpretation, and pathophysiology of an increased cardiac troponin concentration in this setting.</jats:p> </jats:sec> <jats:sec> <jats:title>Content</jats:title> <jats:p>The purpose of this mini-review is: a) to review the pathophysiology of SARS-CoV-2 and the cardiovascular system, b) to overview the strengths and weaknesses of selected studies evaluating cardiac troponin in patients with COVID-19, and c) to recommend testing strategies in the acute period, in the convalescence period and in long-term care for patients who have become ill with COVID-19.</jats:p> </jats:sec> <jats:sec> <jats:title>Summary</jats:title> <jats:p>This review provides important educational information and identifies gaps in understanding the role of cardiac troponin and COVID-19. Future, properly designed studies will hopefully provide the much-needed evidence on the path forward in testing cardiac troponin in patients with COVID-19.</jats:p> </jats:sec>-
dc.publisherOxford University Press (OUP)-
dc.subjectCOVID-19-
dc.subjectacute care-
dc.subjectcardiac troponin-
dc.subjectrisk stratification-
dc.subjectBiomarkers-
dc.subjectCOVID-19-
dc.subjectCardiovascular Diseases-
dc.subjectHumans-
dc.subjectPandemics-
dc.subjectSARS-CoV-2-
dc.subjectSensitivity and Specificity-
dc.subjectTroponin-
dc.titleCardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results-
dc.typeArticle-
dc.date.updated2021-06-08T17:57:25Z-
dc.date.embargo2022-06-08-
dc.date.embargoset12 months-
dc.identifier.doihttps://doi.org/10.1093/clinchem/hvaa225-
Appears in Collections:Faculty Publications (via McMaster Experts)

Files in This Item:
File Description SizeFormat 
Cardiac Troponin Testing in Patients with COVID-19 A Strategy for Testing and Reporting Results.pdf
Access is allowed from: 2022-06-07
Published version631.62 kBAdobe PDFView/Open
Show simple item record Statistics


Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.

Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue